161 related articles for article (PubMed ID: 37422180)
1. Dopaminergic neuroprotective effects of inosine in MPTP-induced parkinsonian mice via brain-derived neurotrophic factor upregulation.
Khanal S; Bok E; Kim J; Park GH; Choi DY
Neuropharmacology; 2023 Nov; 238():109652. PubMed ID: 37422180
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of hyperoside in MPP
Xu XJ; Pan T; Fan HJ; Wang X; Yu JZ; Zhang HF; Xiao BG; Li ZY; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Mar; 38(3):1035-1050. PubMed ID: 36576692
[TBL] [Abstract][Full Text] [Related]
4. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
[TBL] [Abstract][Full Text] [Related]
5. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
6. Intermittent fasting protects the nigral dopaminergic neurons from MPTP-mediated dopaminergic neuronal injury in mice.
Ojha U; Khanal S; Park PH; Hong JT; Choi DY
J Nutr Biochem; 2023 Feb; 112():109212. PubMed ID: 36370926
[TBL] [Abstract][Full Text] [Related]
7. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis.
Yu Y; Lang XY; Li XX; Gu RZ; Liu QS; Lan R; Qin XY
Food Funct; 2019 Sep; 10(9):6009-6019. PubMed ID: 31482900
[TBL] [Abstract][Full Text] [Related]
8. Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase.
Kang SS; Wu Z; Liu X; Edgington-Mitchell L; Ye K
Neurotherapeutics; 2022 Jul; 19(4):1283-1297. PubMed ID: 35595958
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue protects dopaminergic neurons against MPTP-induced neurotoxicity by upregulating brain-derived neurotrophic factor.
Bhurtel S; Katila N; Neupane S; Srivastav S; Park PH; Choi DY
Ann N Y Acad Sci; 2018 Nov; 1431(1):58-71. PubMed ID: 29882218
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease.
Chang E; Wang J
Brain Behav; 2021 Aug; 11(8):e2251. PubMed ID: 34132500
[TBL] [Abstract][Full Text] [Related]
11. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
12. Feruloylated oligosaccharides ameliorate MPTP-induced neurotoxicity in mice by activating ERK/CREB/BDNF/TrkB signalling pathway.
Ding Y; Zhou M; Zheng R; Ma R; Deng J; Hao WZ; Wang L; Zhang JC; Ho CT; Huang JQ
Phytomedicine; 2023 Jan; 108():154512. PubMed ID: 36288652
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
[TBL] [Abstract][Full Text] [Related]
14. The BDNF-TrkB signaling pathway is partially involved in the neuroprotective effects of hydrogen sulfide in Parkinson's disease.
Hacioglu G; Cirrik S; Tezcan Yavuz B; Tomruk C; Keskin A; Uzunoglu E; Takir S
Eur J Pharmacol; 2023 Apr; 944():175595. PubMed ID: 36804547
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
16. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
17. BDNF alleviates Parkinson's disease by promoting STAT3 phosphorylation and regulating neuronal autophagy.
Geng X; Zou Y; Li J; Li S; Qi R; Yu H; Zhong L
Cell Tissue Res; 2023 Sep; 393(3):455-470. PubMed ID: 37450039
[TBL] [Abstract][Full Text] [Related]
18. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity.
Srivastav S; Neupane S; Bhurtel S; Katila N; Maharjan S; Choi H; Hong JT; Choi DY
J Nutr Biochem; 2019 Jul; 69():73-86. PubMed ID: 31063918
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
20. 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
Shi L; Jia L; Wang Y; Xiu M; Xie J
Neurochem Res; 2023 Jun; 48(6):1707-1715. PubMed ID: 36602724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
